VolitionRx Limited (VNRX) is a publicly traded Healthcare sector company. As of July 21, 2026, VNRX trades at $1.17 with a market cap of $13.61M and a P/E ratio of 0.00. VNRX moved +2.65% today. Year to date, VNRX is -78.29%; over the trailing twelve months it is -92.84%. Its 52-week range spans $1.09 to $18.80. Analyst consensus is buy with an average price target of $14.00. Rallies surfaces VNRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
VNRX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. VNRX recently traded at $1.17. Market cap is $13.61M. P/E ratio is 0.00. Revenue is $2.47M.
| Metric | Value |
|---|---|
| Price | $1.17 |
| Market Cap | $13.61M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $18.80 |
| 52-Week Low | $1.09 |
| Volume | 293.65K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.47M |
| Net Income | $-24.73M |
| Gross Margin | 0.00% |
3 analysts cover VNRX: 0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $14.00.